£4m investment in post-mortem cancer study

A £4 million expansion of the UK’s first national post-mortem cancer study has been announced today (13 May, 2016) by Cancer Research UK.

The PEACE (posthumous tissue donation in cancer) study was launched last year at University College London and is now going national.

Post-mortem samples are being collected from up to 500 patients who died from their disease to discover what happens during the final stages of the disease.

Terminally ill patients, most of whom are taking part in clinical trials, at seven hospitals – Cancer Research UK Belfast Centre, Cancer Research Cambridge Centre, Cancer Research UK Glasgow Centre, the Francis Crick Institute, Cancer Research UK Leicester Centre, Cancer Research UK Manchester Centre and King’s College London (Guy’s and St Thomas’ Trust) – will be asked if they are prepared to donate samples for this pioneering research, providing scientists with a detailed timeline of the biological changes in a patient’s cancer from diagnosis to death.

Tumour samples from the original cancer site and other organs where the cancer may have spread, along with cancer cells and DNA found in blood samples, will be analysed.

Doctors say the research is particularly important for research into brain tumours and cancers such as lung cancer, which often spread to the brain, because samples often cannot be taken from patients when they are alive.

Professor Charles Swanton, scientific lead from the Cancer Research UK UCL Centre and Francis Crick Institute, said: “Until this study, we really didn’t have any way nationally to take samples from multiple sites of cancer within a patient at the end of their life. This study will help us complete the whole cancer picture – from diagnosis to death – that we need, in order to understand how it changes and evolves over time and how drug resistance occurs.”

Lydia Knott, aged 79 from Newtown Linford, Leicestershire, who was diagnosed with lung cancer two years ago, even though she has never smoked, has agreed to participate.

“I had no qualms about agreeing to take part. I didn’t even have to go away and think about it; I said yes immediately,” she said.

“I understand it’s a sensitive area and not everyone is going to feel comfortable about this topic. But my view is that if it helps other people and helps to advance research into cancer treatments then it can only be a positive study.

“I have a very clear understanding of what it involves and my children back my decision. At the moment I’m very fit, active and mobile but if, after my death, parts of my body can be used for valuable research purposes, I’m more than happy with this.”

Dr Iain Foulkes, executive director for research funding at Cancer Research UK, said: “When the study opened in London last year, there was an overwhelming number of patients who wanted to contribute to research after their death.

“This was incredibly humbling and now with this investment more people will be able to leave a life-changing legacy and help accelerate research that could benefit thousands of people in the future.”

The study is one of four that will benefit from a total of £16 million investment from Cancer Research UK, the charity announced today.

As well as the PEACE study investment, the Cancer Research UK ICR Centre will receive more than £4 million to study three advanced radiotherapy techniques for patients with hard-to-treat oesophageal and lung cancer.

Cancer Research UK Southampton Centre will also have £4 million to investigate how tumours respond to immunotherapy, while Cancer Research UK Edinburgh Centre is to receive £4 million to launch a research resource into brain tumours.

,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index